JAMIE LEWIS: Open Payments
NPI 1447758305 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,401 in 84 payments from 17 companies in 2025. Trend: 2023 $1,866 · 2024 $1,543 · 2025 $1,401
Food & beverage: $1,401
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $233 |
| Ardelyx, Inc. | 13 | $233 |
| Lilly USA, LLC | 10 | $164 |
| Novo Nordisk Inc | 17 | $154 |
| PFIZER INC. | 7 | $125 |
| ABBVIE INC. | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Tris Pharma Inc | 3 | $52 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
Products named: IBSRELA, AIRSUPRA, MOUNJARO, VRAYLAR, JARDIANCE, ELIQUIS, FARXIGA, Ozempic.
Industry payments across GA — which companies pay providers there.
